131 related articles for article (PubMed ID: 7652184)
1. The 5-lipoxygenase pathway in cultured human intestinal epithelial cells.
Cortese JF; Spannhake EW; Eisinger W; Potter JJ; Yang VW
Prostaglandins; 1995 Mar; 49(3):155-66. PubMed ID: 7652184
[TBL] [Abstract][Full Text] [Related]
2. Lipoxygenase products and expression of 5-lipoxygenase and 5-lipoxygenase-activating protein in human cultured synovial cells.
Bonnet C; Bertin P; Cook-Moreau J; Chable-Rabinovitch H; Treves R; Rigaud M
Prostaglandins; 1995 Sep; 50(3):127-35. PubMed ID: 8750209
[TBL] [Abstract][Full Text] [Related]
3. 5-lipoxygenase and FLAP.
Peters-Golden M; Brock TG
Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):99-109. PubMed ID: 12895592
[TBL] [Abstract][Full Text] [Related]
4. On the expression and regulation of 5-lipoxygenase in human lymphocytes.
Jakobsson PJ; Steinhilber D; Odlander B; Rådmark O; Claesson HE; Samuelsson B
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3521-5. PubMed ID: 1314391
[TBL] [Abstract][Full Text] [Related]
5. 5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase.
Abramovitz M; Wong E; Cox ME; Richardson CD; Li C; Vickers PJ
Eur J Biochem; 1993 Jul; 215(1):105-11. PubMed ID: 8344271
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells.
Riddick CA; Ring WL; Baker JR; Hodulik CR; Bigby TD
Eur J Biochem; 1997 May; 246(1):112-8. PubMed ID: 9210472
[TBL] [Abstract][Full Text] [Related]
7. Expression of 5-lipoxygenase in lymphoblastoid B and T cells.
el Makhour-Hojeij Y; Baclet MC; Chable-Rabinovitch H; Beneytout JL; Cook J
Prostaglandins; 1994 Jul; 48(1):21-9. PubMed ID: 7972877
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory 5-LOX mRNA and protein are increased in brain of aging rats.
Qu T; Uz T; Manev H
Neurobiol Aging; 2000; 21(5):647-52. PubMed ID: 11016533
[TBL] [Abstract][Full Text] [Related]
9. Effect of dexamethasone on leukotriene synthesis in DMSO-stimulated HL-60 cells.
Zaitsu M; Hamasaki Y; Yamamoto S; Kita M; Hayasaki R; Muro E; Kobayashi I; Matsuo M; Ichimaru T; Miyazaki S
Prostaglandins Leukot Essent Fatty Acids; 1998 Dec; 59(6):385-93. PubMed ID: 10102384
[TBL] [Abstract][Full Text] [Related]
10. 5-Lipoxygenase-activating protein rescues activity of 5-lipoxygenase mutations that delay nuclear membrane association and disrupt product formation.
Gerstmeier J; Newcomer ME; Dennhardt S; Romp E; Fischer J; Werz O; Garscha U
FASEB J; 2016 May; 30(5):1892-900. PubMed ID: 26842853
[TBL] [Abstract][Full Text] [Related]
11. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
[TBL] [Abstract][Full Text] [Related]
12. Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAP.
Klegeris A; McGeer PL
J Leukoc Biol; 2003 Mar; 73(3):369-78. PubMed ID: 12629151
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids.
Martel-Pelletier J; Mineau F; Fahmi H; Laufer S; Reboul P; Boileau C; Lavigne M; Pelletier JP
Arthritis Rheum; 2004 Dec; 50(12):3925-33. PubMed ID: 15593193
[TBL] [Abstract][Full Text] [Related]
14. Role of arachidonic acid metabolites on the control of non-differentiated intestinal epithelial cell growth.
Cabral M; Martín-Venegas R; Moreno JJ
Int J Biochem Cell Biol; 2013 Aug; 45(8):1620-8. PubMed ID: 23685077
[TBL] [Abstract][Full Text] [Related]
15. Expression of 5-lipoxygenase and 5-lipoxygenase-activating protein in human fetal membranes throughout pregnancy and at term.
Brown NL; Slater DM; Alvi SA; Elder MG; Sullivan MH; Bennett PR
Mol Hum Reprod; 1999 Jul; 5(7):668-74. PubMed ID: 10381823
[TBL] [Abstract][Full Text] [Related]
16. Expression of 5-lipoxygenase and 5-lipoxygenase-activating protein mRNAs in the peripheral blood leukocytes of asthmatics.
Koshino T; Takano S; Houjo T; Sano Y; Kudo K; Kihara H; Kitani S; Takaishi T; Hirai K; Ito K; Morita Y
Biochem Biophys Res Commun; 1998 Jun; 247(2):510-3. PubMed ID: 9642160
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the interaction of human 5-lipoxygenase with its activating protein FLAP.
Häfner AK; Gerstmeier J; Hörnig M; George S; Ball AK; Schröder M; Garscha U; Werz O; Steinhilber D
Biochim Biophys Acta; 2015 Nov; 1851(11):1465-72. PubMed ID: 26327594
[TBL] [Abstract][Full Text] [Related]
18. Regulation of 5-lipoxygenase and 5-lipoxygenase-activating protein expression in HL-60 cells.
Bennett CF; Chiang MY; Monia BP; Crooke ST
Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):33-9. PubMed ID: 8380989
[TBL] [Abstract][Full Text] [Related]
19. 5-LOX, 12-LOX and 15-LOX in immature forms of human leukemic blasts.
Vincent C; Fiancette R; Donnard M; Bordessoule D; Turlure P; Trimoreau F; Denizot Y
Leuk Res; 2008 Nov; 32(11):1756-62. PubMed ID: 18561999
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of cell density on 5-lipoxygenase (5-LO), five-lipoxygenase-activating protein (FLAP) and interleukin-1 beta (IL-1 beta) expression in human neutrophils.
Jobin C; Gauthier J
Inflammation; 1997 Apr; 21(2):235-50. PubMed ID: 9187965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]